NetworkNewsBreaks

ThursdayJan 30, 2020 10:30 am

NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Receives SofPulse(R) Orders From Multiple Plastic Surgery Centers

Endonovo Therapeutics (OTCQB: ENDV) today announced that it has secured sales of SofPulse(R), the company’s FDA-Cleared, non-invasive device utilized for the reduction of postoperative pain and edema, to multiple plastic surgery centers. “SofPulse(R) main distribution model is marketing to major hospitals throughout the US and is beginning to be viewed as the standard of care for postoperative pain and edema reduction for numerous inpatient hospital procedures. With the expansion of our customer base and recent orders from numerous plastic surgery centers, SofPulse(R) demonstrates different applications for its use,” Endonovo Therapeutics CEO Alan Collier stated in the news release. “We are…

Continue Reading

ThursdayJan 30, 2020 9:52 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Foresight Affiliate Rail Vision in Advanced Negotiations with Leading European Train Operator for First Commercial Agreement

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its affiliate, Rail Vision Ltd., is in advanced negotiations regarding its first commercial agreement with a leading European train operator. The agreement contemplates the purchase of a prototype system of Rail Vision’s shunting yard solution for a total value of approximately 500,000 Euro and, upon successful prototype evaluation, will entail the purchase of approximately 30 more shunting yard systems for an additional 2.5 million Euro. In addition, the European train operator may exercise its option to purchase an additional 45 shunting yard systems for…

Continue Reading

WednesdayJan 29, 2020 1:51 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Accelerates Delivery of CBD into Bloodstream

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) 2.0 version of its patented DehydraTECH(TM) oral drug-delivery technology has demonstrated its power to deliver more cannabidiol (“CBD”) into the bloodstream than generic industry-control formulations (http://nnw.fm/SR9dw). An article discussing the company reads, “The company’s 2.0 technology is specifically being developed for effectiveness in helping to deliver its drug payload across the blood-brain barrier, a natural biological system of blood vessels and endothelial cells that bar most drugs from accessing the brain’s central-nervous-system hierarchy. The ability to effectively deliver drugs to the brain is of keen interest to developers of drugs designed to beneficially target the…

Continue Reading

WednesdayJan 29, 2020 1:45 pm

NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) Advancing CBD Initiatives

ChineseInvestors.com (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, is capitalizing on the rising demand for cannabidiol (“CBD”)-based nutrition and health products. A recent article discussing the company reads, “CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health-products market in mainland China. . . .…

Continue Reading

WednesdayJan 29, 2020 1:15 pm

NetworkNewsBreaks – Orion Energy Systems, Inc.’s (NASDAQ: OESX) Competitive Position Featured in Roth Equity Research Report

Orion Energy Systems (NASDAQ: OESX) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “Orion announced $18m-$20m incremental purchase indications from Home Depot (HD-NC), bringing the total HD orders to ~$130m. This announcement raises credibility for Orion's competitive position looking to steal one of Acuity's (AYI-Sell) Top-5 customers, where we expect visibility will greatly improve in coming weeks. Home Depot was originally an Acuity customer, and Orion is delivering a fully-custom retrofit package that avoids depreciation charges for the customer, while offering a $40 retrofit solution vs. the $200 Acuity alternative.” To…

Continue Reading

WednesdayJan 29, 2020 12:44 pm

NetworkNewsBreaks – Adaptimmune Therapeutics plc (NASDAQ: ADAP) Secures $84M in Underwritten Public Offering

Adaptimmune Therapeutics (NASDAQ: ADAP), a leader in T-cell therapy to treat cancer, has closed an underwritten public offering of 21,000,000 of its American Depositary Shares (“ADSs”). According to the update, Adaptimmune Therapeutics secured gross proceeds of $84 million in the offering, with each of the ADSs sold at the public offering price of $4.00. Adaptimmune has, in connection with the offering, granted the underwriters a 30-day option to purchase up to an additional 3,150,000 ADSs at the public offering price. All ADSs in this offering are sold by Adaptimmune Therapeutics, which intends to use the proceeds to advance the development…

Continue Reading

WednesdayJan 29, 2020 12:38 pm

NetworkNewsBreaks – Sharps Compliance Corp.’s (NASDAQ: SMED) Outperformance, Solid Growth Featured in Roth Equity Research Report

Sharps Compliance (NASDAQ: SMED) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “Sharps outperformed across the board as all of its segments posted solid growth. Importantly, Unused Medications and Route-based Collection continued their growth trajectories. These segments provide substantially larger addressable markets, have consistent revenue profiles and are key to future growth and valuation. We anticipate continued 15%+ overall company growth in F2020 with acquisitions potentially aiding Route-based collections by adding customer density.” To view the full report, visit http://nnw.fm/1rpnT About Sharps Compliance Corp. Headquartered in Houston, Texas, Sharps Compliance is…

Continue Reading

WednesdayJan 29, 2020 11:53 am

NetworkNewsBreaks – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) to Host Expert Call on Coronavirus Implications Both Near its Source and Closer to Home

Inovio Pharmaceuticals (NASDAQ: INO) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. According to the update, the company intends to host a conference call at 10:30 a.m. EST on Monday, February 3, 2020, during which Dr. David B. Weiner, Ph.D. will discuss implications of the coronavirus epidemic both near its source and closer to home, given the recent outbreak of a new strain in China and its spread to North America. Dr Weiner is executive vice president of the Wistar Institute, director of Vaccine & Immunotherapy Center, and professor emeritus at the University of…

Continue Reading

WednesdayJan 29, 2020 11:25 am

NetworkNewsBreaks – QuickLogic Corp (NASDAQ: QUIK) Featured as “Differentiated Sensor Processing and AI Platform Investment Opportunity” in Roth Equity Research Report

QuickLogic Corp (NASDAQ: QUIK) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “We believe QUIK represents a differentiated sensor processing and AI platform investment opportunity. We are encouraged by QUIK’s decision to reduce its workforce by nearly one-third. QUIK also provided preliminary reaffirmation of its prior 4Q19 guidance for revenue. We now expect ‘20e growth to results in a closer break-even than prior to the restructuring announcement. We lower our price target from $8.50 to $6.50 and maintain to Neutral.” To view the full report, visit http://nnw.fm/I5t1N About QuickLogic Corp QuickLogic…

Continue Reading

WednesdayJan 29, 2020 10:51 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Announces New, Bold Shift in Business Strategy, Eyes On-Demand Revolution of the Cannabis Sector

Sugarmade (OTCQB: SGMD) today announced a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. According to the update, Sugarmade will make several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and new relationships with proven sector business operators. “Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is…

Continue Reading